Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00706
|
|||||
| Drug Name |
Cefuroxime
|
|||||
| Synonyms |
(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(carbamoyloxy)methyl]-7-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-(2-(2-Furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime) carbamate (ester); 3-[(carbamoyloxy)methyl]-7beta-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-3,4-didehydrocepham-4-carboxylic acid; Anaptivan; Biociclin; Biofuroksym; Bioxima; CEFUROXIME SODIUM; CXM; Cefofix; Ceftin (TN); Cefumax; Cefurex; Cefuril; Cefuroxim; Cefuroxim AJ; Cefuroxim Fresenius; Cefuroxim Genericsn; Cefuroxim Hexal; Cefuroxim Lilly; Cefuroxim MN; Cefuroxim Norcox; Cefuroxim Norcox [inj.]; Cefuroxim curasan; Cefuroxima Fabra; Cefuroxima Richet; Cefuroxime (TN); Cefuroxime (USAN/INN); Cefuroxime [USAN:INN:BAN]; Cefuroxime for Injection and Dextrose for Injection in Duplex Container; Cefuroxime na; Cefuroxime sodium (JP15/USP); Cefuroxime sodium [USAN:BAN:JAN]; Cefuroxime sodium salt; Cefuroximesodium; Cefuroximine; Cefuroximo; Cefuroximo [INN-Spanish]; Cefuroximum; Cefuroximum [INN-Latin]; Cephuroxime; Cetroxil; Cetroxil [inj.]; Colifossim; Curocef; Curoxim; Curoxima; Curoxime; Froxal; Froxal [inj.]; Furoxil; KEFUROX IN PLASTIC CONTAINER; KS-1040; Kesint; Ketocef; Lifurox; Medoxim; Sharox; Sharox [inj.]; Sodium (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), carbamate (ester); Sodium (6R-(6alpha,7beta(Z)))-3-(((aminocarbonyl)oxy)methyl)-7-(2-furyl(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; Sodium cefuroxime; Spectrazolr; Ultroxim; ZINACEF IN PLASTIC CONTAINER; Zinacef (TN); Zinacef Danmark; Zinacef;CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER; Zinnat (TN); Zinnat [inj.]
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C16H15N4NaO8S
|
|||||
| Canonical SMILES |
CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-].[Na+]
|
|||||
| InChI |
InChI=1S/C16H16N4O8S.Na/c1-26-19-9(8-3-2-4-27-8)12(21)18-10-13(22)20-11(15(23)24)7(5-28-16(17)25)6-29-14(10)20;/h2-4,10,14H,5-6H2,1H3,(H2,17,25)(H,18,21)(H,23,24);/q;+1/p-1/b19-9-;/t10-,14-;/m1./s1
|
|||||
| InChIKey |
URDOHUPGIOGTKV-JTBFTWTJSA-M
|
|||||
| CAS Number |
CAS 55268-75-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 446.4 | Topological Polar Surface Area | 202 | ||
| Heavy Atom Count | 30 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 10 | |||
| PubChem CID | ||||||
| PubChem SID |
10308
,117664401
,121363576
,124766425
,126629706
,126655800
,126686329
,135004234
,137267224
,14833063
,14881773
,152101191
,162225020
,163316243
,164788191
,170524605
,175265786
,175611978
,179316275
,187072187
,196112116
,223439274
,223674139
,227008553
,24892692
,252122164
,252402066
,25819900
,43176102
,50050864
,56041334
,57260152
,57264411
,57387187
,57654015
,77146479
,7847978
,8139982
,89736081
,92713907
|
|||||
| ChEBI ID |
ChEBI:3515
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.